Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
ASCO Highlights
ASCO Highlights
,
Prostate Cancer
Continuous Treatment with Enzalutamide and Docetaxel Reduces the Risk for Progression in Patients with Metastatic Castration-Resistant Prostate Cancer
Read More
Meeting Highlights
Multiple Myeloma
,
ASCO Highlights
New CAR T-Cell Therapy Produces Durable Responses in Relapsed or Refractory Multiple Myeloma
Wayne Kuznar
Wayne Kuznar
Read More
Meeting Highlights
Biosimilars
,
ASCO Highlights
Rapid Biosimilar Adoption Possible in Community Oncology Practice
Chase Doyle
Chase Doyle
Read More
Meeting Highlights
Lung Cancer
,
ASCO Highlights
Atezolizumab Extends Disease-Free Survival in PD-L1−Positive Early-Stage NSCLC
Phoebe Starr
Phoebe Starr
Read More
Meeting Highlights
Prostate Cancer
,
ASCO Highlights
¹⁷⁷Lu-PSMA-617 Prolongs Survival in Patients with Metastatic Castration-Resistant Prostate Cancer
Phoebe Starr
Phoebe Starr
Read More
Meeting Highlights
ASCO Highlights
ASCO 2020 Lung Cancer Highlights
Read More
Meeting Highlights
ASCO Highlights
Clinical Activity of the RET Inhibitor Pralsetinib (BLU-667) in Patients with RET-Altered Solid Tumors
Read More
Meeting Highlights
ASCO Highlights
Clinical Activity of Pralsetinib (BLU-667) in Patients with Advanced RET Fusion–Positive NSCLC
Read More
Meeting Highlights
ASCO Highlights
AcceleRET Lung: A Phase 3 Study of Pralsetinib in Patients with RET Fusion–Positive Metastatic NSCLC
Read More
Meeting Highlights
ASCO Highlights
Efficacy of Capmatinib in Second-Line Treatment of Patients with METex14-Mutated NSCLC
Read More
1
2
3
4
5
Page 2 of 5
Results 11 - 20 of 42